{"id":158255,"date":"2018-06-28T00:00:00","date_gmt":"2018-06-28T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/m360ca0013-medtech-coronary-artery-bypass-graft-devices-market\/"},"modified":"2026-04-17T23:09:42","modified_gmt":"2026-04-17T23:09:42","slug":"m360ca0013-medtech-coronary-artery-bypass-graft-devices-market-insights-europe","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360ca0013-medtech-coronary-artery-bypass-graft-devices-market-insights-europe\/","title":{"rendered":"Coronary Artery Bypass Graft Devices &#8211; Market Insights &#8211; Europe"},"content":{"rendered":"<p>\n\tThe mature European <abbr title=\"Coronary Artery Bypass Graft\">CABG<\/abbr> device market will contract modestly through 2026 as procedure volumes decline due to increasing use of <abbr title=\"Percutaneous Coronary Intervention\">PCI<\/abbr> for the treatment of <abbr title=\"Coronary Artery Disease\">CAD<\/abbr>; however, rising interest in <abbr title=\"Off-Pump Coronary Artery Bypass\">OPCAB<\/abbr> and minimally invasive approaches to <abbr title=\"Coronary Artery Bypass Graft\">CABG<\/abbr> surgery will help to mitigate overall revenue declines to some extent.<\/p>\n<p>\n\tThis Medtech 360 Report provides comprehensive data and analysis on the current state of the market for\u00a0<abbr title=\"Coronary Artery Bypass Graft\">CABG<\/abbr>\u00a0devices in Europe across a 10-year period.<\/p>\n<p class=\"question-statement\">\n\t<strong>Surgical revascularization via\u00a0<abbr title=\"Coronary Artery Bypass Graft\">CABG<\/abbr>\u00a0surgery for\u00a0<abbr title=\"Coronary Artery Disease\">CAD<\/abbr>\u00a0patients is facing increasing competition from alternative treatments such as\u00a0<abbr title=\"Percutaneous Coronary Intervention\">PCI<\/abbr>\u00a0and medical management.\u00a0<\/strong><\/p>\n<p>\n\tWhat is the rate of decline for\u00a0<abbr title=\"Coronary Artery Bypass Graft\">CABG<\/abbr>\u00a0procedure volumes in Europe?<\/p>\n<p>\n\tIn which specific indications will\u00a0<abbr title=\"Coronary Artery Bypass Graft\">CABG<\/abbr>\u00a0procedure volumes increase?<\/p>\n<p>\n\tWhat impact will recent and ongoing clinical trials have on\u00a0<abbr title=\"Coronary Artery Bypass Graft\">CABG<\/abbr>\u00a0procedure volumes and clinical guidelines for coronary revascularization in the Europe?<\/p>\n<p class=\"question-statement\">\n\t<strong>The <abbr title=\"Coronary Artery Bypass Graft\">CABG<\/abbr> device market is highly mature, highly competitive, and <span>dominated<\/span> by several large <abbr title=\"Multinational Corporation\">MNC<\/abbr>s.<\/strong><\/p>\n<p>\n\tWho are the companies with a major foothold in this market?<\/p>\n<p>\n\tWhat strategies are adopted by these companies to tackle the highly competitive nature of the market?<\/p>\n<p>\n\tWhat other factors are also presenting challenges to companies within this segment?<\/p>\n<p class=\"question-statement\">\n\t<strong>Price competition will limit revenue growth potential, especially in light of increased cost-consciousness among health care\u00a0facilities. \u00a0<\/strong><\/p>\n<p>\n\tWhich segments will experience the most price competition?<\/p>\n<p>\n\tIn which segments and to what extent will adoption of premium-priced next-generation products offset the effects of price competition?\u00a0<\/p>\n<p>\n\tWhat strategies may\u00a0<abbr title=\"Coronary Artery Bypass Graft\">CABG<\/abbr>\u00a0device manufacturers adopt to address the increasing cost-consciousness among health care facilities?\u00a0<\/p>\n","protected":false},"template":"","class_list":["post-158255","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-coronary-artery-bypass-graft-devices","medtech-geography-europe","medtech-date-918"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/158255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/158255\/revisions"}],"predecessor-version":[{"id":289319,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/158255\/revisions\/289319"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=158255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}